Combating COVID-19 – Monoclonal Antibody Therapies to Optimize Patient Care: HHS/ASPR COVID-19 Therapeutics program

IE users – if you are experiencing issues trying to register for this webinar, please use Chrome, Safari or Firefox.

Wednesday, May 5, 2021
12:00 PM ET/9:00 AM PT

Monoclonal Antibody Therapies to Optimize Patient Care & Combat COVID-19
 
 
Program objectives include:
Increasing awareness and utilization of monoclonal antibody therapy
Presenting recent updates on the efficacy of this therapy against COVID-19 variants
Closing the gap in knowledge about appropriate use of monoclonal antibodies
Q&A
 
 
Presenters:
Meredith Chuk
MD, FAAP 
Lead, COVID-19 Therapeutics Team Office of the Assistant Secretary of Preparedness and Response (ASPR)
US Dept. of Health and Human Services
 
 
Christian B. Ramers
MD, MPH, AAHIVS 
Chief, Population Health and Director, Graduate Medical Education  Family Health Centers of San Diego
 
 
Adolphe Edward 
DrHA, MBA, MSHA
Chief Executive Officer,  
El Centro Regional Medical Center
El Centro, CA
 
 
Vivien Dugan, PhD 
Lead, Strain Surveillance and Emerging Variants Team, Laboratory & Testing Task Force, COVID-19 Emergency Response Team CDC 
 
 
Hema Kapoor, MD
D (ABMM), SM
Senior Medical Director, 
Infectious Diseases & Immunology and Global Diagnostics Network Quest Diagnostics
Secaucus, NJ
 
 
Moderator:
Michael R. Anderson
MD, MBA, FAAP
Senior Advisor, Office of the   Assistant Secretary of Preparedness and Response (ASPR)
US Dept. of Health and Human Services